IRVINE, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Sientra, Inc. SIEN (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced that the Food and Drug Administration (FDA) has granted a 510(k) clearance for the Company’s novel Portfinder™ technology. Portfinder™…Read More
Sientra Announces FDAClearance of Novel Portfinder Technology Sientra NASDAQSIEN
